Thomas J. Herzfeld Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-625
| Closed | -$28.4K | – | 204 |
|
|
2023
Q3 | $28.4K | Hold |
625
| – | – | 0.01% | 142 |
|
|
2023
Q2 | $35.1K | Hold |
625
| – | – | 0.01% | 135 |
|
|
2023
Q1 | $28.3K | Hold |
625
| – | – | 0.01% | 120 |
|
|
2022
Q4 | $25.4K | Hold |
625
| – | – | 0.01% | 126 |
|
|
2022
Q3 | $41K | Hold |
625
| – | – | 0.02% | 104 |
|
|
2022
Q2 | $38K | Hold |
625
| – | – | 0.02% | 119 |
|
|
2022
Q1 | $39K | Buy |
625
+225
| +56% | +$14K | 0.01% | 128 |
|
|
2021
Q4 | $30K | Hold |
400
| – | – | 0.01% | 160 |
|
|
2021
Q3 | $45K | Sell |
400
-15
| -4% | -$1.69K | 0.02% | 139 |
|
|
2021
Q2 | $67K | Sell |
415
-2
| -0.5% | -$323 | 0.03% | 131 |
|
|
2021
Q1 | $51K | Buy |
417
+400
| +2,353% | +$48.9K | 0.02% | 146 |
|
|
2020
Q4 | $3K | Hold |
17
| – | – | ﹤0.01% | 258 |
|
|
2020
Q3 | $2K | Buy |
+17
| New | +$2K | ﹤0.01% | 234 |
|